Mobile banner background
i2e Elevate

Decision integrity: Building confidence into every portfolio decision

April 23, 2027
Boston, MA

About i2e Elevate

i2e Elevate is an invitation-only forum where senior R&D, portfolio and clinical operations leaders come together to work through the decisions that shape drug development.

Rather than a stage of presentations, Elevate is built around candid peer conversation, with breakout sessions where leaders think out loud about the challenges they face. 

Over the past two editions, Elevate has grown into one of the most anticipated forums for pharma R&D leadership. In 2025, Elevate explored how to “Build the foundation for next-generation SPM excellence.” 

In 2026, Elevate brought together around 40 senior leaders in New York under the theme "Connected decisions: Accelerating outcomes from portfolio to patient." 

Elevate 2027 carries that conversation forward, focusing on how organizations align to turn portfolio strategy into confident execution.

Two tracks. One forum.

Decision integrity starts in the portfolio and holds all the way through clinical execution. Elevate 2027 brings both conversations into the same room.

Strategic Portfolio Management

For portfolio, governance and PMO leaders shaping where R&D invests.

  • Portfolio prioritization and scenario planning
  • Capacity and resource planning across the pipeline
  • Governance models that hold up under pressure
  • The agentic PMO: where AI is changing portfolio decisions
  • A vendor panel with leading SPM and data platform partners

Clinical Data Services

For clinical operations, data management and quality leaders turning trial data into decisions.

  • Risk-based quality management and central monitoring
  • Owning your clinical data and risk intelligence
  • Connecting clinical data across platforms and partners
  • AI in clinical data review and oversight
  • Staying inspection-ready as trials scale

Who should attend?

  • tick
    Portfolio strategy & governance leaders
  • tick
    R&D operations and PMO executives

Why should you attend? 

icon
Real challenges, real solutions
Our agenda is expert curated and industry vetted. It is designed to answer questions or invoke discussions for topics that you have been struggling with.
icon
Knowledge sharing
It’s a room of R&D and PMO leaders openly sharing what’s working, what’s failing, and what they’d do differently if they could start over. You’ll hear your how peers are approaching similar issues — from resource algorithms to scenario planning — and what’s actually working.
icon
Cross industry perspective
What could pharma R&D ops learn from other capital intensive industries? We’ve curated the top case studies and use cases from other industries that will spark discussions and help pharma leaders look at their portfolio challenges with fresh eyes.

Meet us there

Sudhir Karanth 
Sudhir Karanth 
CEO, i2e Consulting 
Vishal Rane
Vishal Rane
COO, i2e Consulting
Sri Kanagala
Sri Kanagala
CDO, i2e Consulting
Peter Green 
Peter Green 
VP- Data & Analytics, i2e Consulting
Carlos Nunes
Carlos Nunes
Strategic Advisor
Dave Penndorf
Dave Penndorf
Strategic Advisor, i2e Consulting 
Angelo Morello
Angelo Morello
VP, Business Development, i2e Consulting 
Moid Ahmad
Moid Ahmad
Director, Growth & Delivery, i2e Consulting 
Vivek Kadam
Vivek Kadam
Sr. Manager,BD i2e Consulting

Join the next wave of portfolio leadership dialogue

Elevate 2026 carried the dialogue forward with stronger insights into portfolio innovation and leadership alignment. Would you like to be part of what comes next?

Join the interest list for Elevate 2027

By submitting this form, you agree to our Terms of Use and Privacy Policy. Information provided by you may be collected and automatically stored in our database and may be used for sending you additional information about i2e Consulting and our services.

SPM Icon
SPM maturity calculator